Cytokine signature in chronic hepatitis C patients treated with peginterferon alpha 2A and ribavirin

被引：0
|
作者：
Neuman, M. G. [1 ,2 ,3 ]
Malkiewicz, I. M. [1 ]
Esguerra, R. [1 ,2 ,3 ]
Sha, K. [1 ,2 ,3 ,5 ]
Mazulli, T. [4 ,5 ]
Moussa, G. [4 ]
Morgan, M. [6 ,7 ]
Cohen, L. [6 ]
机构：
[1] MaRS, In Vitro Drug Safety & BioTechnol, Toronto, ON, Canada
[2] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada
[3] Univ Toronto, Inst Drug Res, Toronto, ON, Canada
[4] Mt Sinai Hosp, Dept Virol & Microbiol, Toronto, ON, Canada
[5] Univ Toronto, Dept Lab Med, Toronto, ON, Canada
[6] Sunnybrook Hlth Sci Ctr, Div Gastroenterol, Toronto, ON, Canada
[7] Univ Toronto, Dept Med, Toronto, ON, Canada
来源：
CLINICAL BIOCHEMISTRY | 2008年 / 41卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：198 / 198
页数：1
相关论文
共 50 条
  • [41] Efficacy and factors influencing treatment with peginterferon alpha-2a and ribavirin in elderly patients with chronic hepatitis C
    Jian-Wu Yu
    Hepatobiliary & Pancreatic Diseases International, 2012, 11 (02) : 185 - 192
  • [42] Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C -: A randomized study of treatment duration and ribavirin dose
    Hadziyannis, SJ
    Sette, H
    Morgan, TR
    Balan, V
    Diago, M
    Marcellin, P
    Ramadori, G
    Bodenheimer, H
    Bernstein, D
    Rizzetto, M
    Zeuzem, S
    Pockros, PJ
    Lin, A
    Ackrill, AM
    ANNALS OF INTERNAL MEDICINE, 2004, 140 (05) : 346 - 355
  • [43] Peginterferon alpha-2a and ribavirin combination therapy for chronic hepatitis C in patients with hemophilia - preliminary report
    Kim, H.
    Yoo, K.
    Lee, K.
    Lee, Y.
    HAEMOPHILIA, 2008, 14 : 41 - 41
  • [44] A Sustained Virologic Response Is Durable in Patients With Chronic Hepatitis C Treated With Peginterferon Alfa-2a and Ribavirin
    Swain, Mark G.
    Lai, Ming-Yang
    Shiffman, Mitchell L.
    Cooksley, W. Graham E.
    Zeuzem, Stefan
    Dieterich, Douglas T.
    Abergel, Armand
    Pessoa, Mario G.
    Lin, Amy
    Tietz, Andreas
    Connell, Edward V.
    Diago, Moises
    GASTROENTEROLOGY, 2010, 139 (05) : 1593 - 1601
  • [45] Efficacy and factors influencing treatment with peginterferon alpha-2a and ribavirin in elderly patients with chronic hepatitis C
    Yu, Jian-Wu
    Sun, Li-Jie
    Kang, Peng
    Yan, Bing-Zhu
    Zhao, Yong-Hua
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2012, 11 (02) : 185 - 192
  • [46] Retreatment with peginterferon and ribavirin in chronic hepatitis C
    Yong Min Jo
    Sung Wook Lee
    Sang Young Han
    Yang Hyun Baek
    Soo Young Kim
    Woo Jae Kim
    Ji Hye Ahn
    Ji Young Lee
    World Journal of Gastroenterology, 2015, (06) : 1994 - 1999
  • [47] Retreatment with peginterferon and ribavirin in chronic hepatitis C
    Jo, Yong Min
    Lee, Sung Wook
    Han, Sang Young
    Baek, Yang Hyun
    Kim, Soo Young
    Kim, Woo Jae
    Ahn, Ji Hye
    Lee, Ji Young
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (06) : 1994 - 1999
  • [48] Peginterferon-α2a in the treatment of chronic hepatitis C
    Akimov, Sergey
    Adeyemi, Oluwatoyin M.
    FUTURE VIROLOGY, 2006, 1 (06) : 689 - 701
  • [49] ADHERENCE RATES FOR PEGINTERFERON plus RIBAVIRIN COMPARED WITH TELAPREVIR plus PEGINTERFERON plus RIBAVIRIN IN MEDICAID AND COMMERCIAL PATIENTS TREATED FOR CHRONIC HEPATITIS C
    Samp, J. C.
    Walker, D.
    Manthena, S.
    Juday, T.
    VALUE IN HEALTH, 2014, 17 (07) : A368 - A368
  • [50] Efficacy of low dose peginterferon alpha-2b with ribavirin on chronic hepatitis C
    Rajesh Gupta
    CH Ramakrishna
    Sandeep Lakhtakia
    Manu Tandan
    Rupa Banerjee
    D Nageshwar Reddy
    World Journal of Gastroenterology, 2006, (34) : 5554 - 5556
12345